Evaluation of the tetracycline-repressible transactivator system for inducible gene expression in human prostate cancer cell lines.
about
Protein kinase A type II-α regulatory subunit regulates the response of prostate cancer cells to taxane treatment.Direct binding of neutral endopeptidase 24.11 to ezrin/radixin/moesin (ERM) proteins competes with the interaction of CD44 with ERM proteins.Two-step transcriptional amplification-lipid-based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer.Overexpression of PKCepsilon sensitizes LNCaP human prostate cancer cells to induction of apoptosis by bryostatin 1.Tetracycline-regulated gene expression mediated by a novel chimeric repressor that recruits histone deacetylases in mammalian cells.
P2860
Evaluation of the tetracycline-repressible transactivator system for inducible gene expression in human prostate cancer cell lines.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Evaluation of the tetracycline ...... an prostate cancer cell lines.
@en
type
label
Evaluation of the tetracycline ...... an prostate cancer cell lines.
@en
prefLabel
Evaluation of the tetracycline ...... an prostate cancer cell lines.
@en
P2093
P1433
P1476
Evaluation of the tetracycline ...... an prostate cancer cell lines.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0045(19971101)33:3<166::AID-PROS4>3.0.CO;2-H
P577
1997-11-01T00:00:00Z